Showing results (71-80 of 174) with videos related to

Sort By:
Pageof 18
Microorganisms|December 16, 2020
Combination of Colistin and Azidothymidine Demonstrates Synergistic Activity against Colistin-Resistant, Carbapenem-Resistant <i>Klebsiella pneumoniae</i>Ya-Ting Chang, Tsung-Ying Yang, Po-Liang Lu, et al.
Scientific Reports|December 4, 2020
ALK variants, PD-L1 expression, and their association with outcomes in ALK-positive NSCLC patientsGee-Chen Chang, Tsung-Ying Yang, Kun-Chieh Chen, et al.
Plos One|May 23, 2014
Pemetrexed induces S-phase arrest and apoptosis via a deregulated activation of Akt signaling pathwayKun-Chieh Chen, Tsung-Ying Yang, Chun-Chi Wu, et al.
Therapeutic Advances in Medical Oncology|November 1, 2024
Real-world clinical efficacy of bevacizumab biosimilar in patients with advanced non-small-cell lung cancerWei-Fan Ou, Kuo-Hsuan Hsu, Jeng-Sen Tseng, et al.
Cancer Research and Treatment|December 12, 2017
Intercalated Treatment Following Rebiopsy Is Associated with a Shorter Progression-Free Survival of Osimertinib TreatmentJeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, et al.
Oncotargets and Therapy|July 1, 2025
Survival Outcomes in Lung Cancer Patients Newly Diagnosed Through Brain Metastasis Surgery: Impact of Druggable Mutations and RadiotherapyTzu-I Chuang, Kuo-Hsuan Hsu, Po-Hsin Lee, et al.
Spine|July 11, 2007
Surgical results of metastatic spinal cord compression secondary to non-small cell lung cancerYen-Jen Chen, Gee-Chen Chang, Hsien-Te Chen, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 9, 2024
Real-world evidence of lorlatinib therapy in Taiwanese patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancerJin-Yuan Shih, Yung-Hung Luo, Gee-Chen Chang, et al.
Materials Science & Engineering. C, Materials for Biological Applications|May 9, 2021
In vitro and in vivo assessments of inspired Ag/80S bioactive nanocomposites against carbapenem-resistant Klebsiella pneumoniaeTsung-Ying Yang, Ya-Ju Hsieh, Po-Liang Lu, et al.
Plos One|November 17, 2018
Mutational monitoring of EGFR T790M in cfDNA for clinical outcome prediction in EGFR-mutant lung adenocarcinomaKang-Yi Su, Jeng-Sen Tseng, Keng-Mao Liao, et al.
Pageof 18